Exploring the choroidal vascular labyrinth and its molecular and structural roles in health and disease

Autor: Brinks, J., van Dijk, E.H.C., Klaassen, I., Schlingemann, R.O., Kielbasa, S.M., Emri, E., Quax, P.H.A., Bergen, A.A., Meijer, O.C., Boon, C.J.F.

Publikováno v: In Progress in Retinal and Eye Research March 2022 87

Crossover to half-dose photodynamic therapy or eplerenone in chronic central serous chorioretinopathy patients

Autor: Feenstra, H.M.A., Dijk, E.H.C. van, Rijssen, T.J. van, Tsonaka, R., Diederen, R.M.H., Schlingemann, R.O., Hoyng, C.B., Boon, C.J.F.

Publikováno v: Ophthalmology Retina, 6(10), 930-938. ELSEVIER INC
Feenstra, H M A, van Dijk, E H C, van Rijssen, T J, Tsonaka, R, Diederen, R M H, Schlingemann, R O, Hoyng, C B & Boon, C J F 2022, ' Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients ', Ophthalmology Retina, vol. 6, no. 10, pp. 930-938 . https://doi.org/10.1016/j.oret.2022.04.014
Ophthalmology Retina, 6(10), 930-938. Elsevier Inc.
Ophthalmology Retina, 6, 930-938
Ophthalmology Retina, 6, 10, pp. 930-938

Purpose: To compare the efficacy and safety of crossover treatment to half-dose photodynamic therapy (PDT) and eplerenone treatment after the failure of primary treatment in patients with chronic central serous chorioretinopathy (cCSC). Design: Multi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76feb7caf99e84b506423c7fb04877e0
http://hdl.handle.net/1887/3485621

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

Autor: Feenstra, H.M.A., Dijk, E.H.C. van, Rijssen, T.J. van, Tsonaka, R., Diederen, R.M.H., Hoyng, C.B., Schlingemann, R.O., Boon, C.J.F.

Publikováno v: Graefe's Archive for Clinical and Experimental Ophthalmology. Springer Verlag
Feenstra, H M A, van Dijk, E H C, van Rijssen, T J, Tsonaka, R, Diederen, R M H, Hoyng, C B, Schlingemann, R O & Boon, C J F 2022, ' Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment : SPECTRA trial report No. 3 ', Graefe's Archive for Clinical and Experimental Ophthalmology . https://doi.org/10.1007/s00417-022-05836-x
Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 659-668
Graefe s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Springer Verlag
Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 3, pp. 659-668
Graefe's Archive for Clinical and Experimental Ophthalmology, 261, 659-668. SPRINGER

Purpose Comparing anatomic and functional efficacy and safety of primary treatment with either half-dose photodynamic therapy (PDT) or oral eplerenone, or crossover treatment in chronic central serous chorioretinopathy patients. Methods After the SPE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d424502f66210a70eee143b0d7accc0
https://research.vumc.nl/en/publications/7995d6a8-fd1c-4b1e-9681-6a10b99477f4

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.